Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer.
Katherine A MichaelisMason A NorgardXinxia ZhuPeter R LevasseurShamilene SivagnanamShannon M LiudahlKevin G BurfeindBrennan OlsonKatherine R PelzDiana M Angeles RamosHans Carlo MaurerKenneth P OliveLisa M CoussensTerry K MorganDaniel L. MarksPublished in: Nature communications (2019)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.